Skip to main content
. Author manuscript; available in PMC: 2018 Oct 22.
Published in final edited form as: Alzheimers Dement. 2018 Jun 28;14(9):1148–1158. doi: 10.1016/j.jalz.2018.04.009

Table 2.

H. pylori seropositivity’s association with incident Alzheimer’s disease and all-cause dementia in multiple Cox proportional hazards regression models, overall and stratified by sex, race, age, income, and education groups: NHANES III, phase 1 (1988–1991) alone and combined with NHANES 1999–2000 (pooled sample)

H. pylori seropositivity
vs. incident outcomes
Model 1* Model 2 Model 3

HR (95% CI) P HR (95% CI) P HR (95% CI) P
Pooled sample
 Alzheimer’ disease
  Overall (N = 5876) 1.19 (0.96–1.49) .11 1.13 (0.90–1.42) .30 1.10 (0.87–1.38) .42
  Men (N = 2937) 1.56 (1.12–2.18) .008§ 1.46 (1.03–2.05) .031§ 1.45 (1.03–2.04) .035§
  Women (N = 2939) 1.03 (0.78–1.37) .82 0.98 (0.73–1.31) .87 0.96 (0.71–1.37) .71
  NH white (N = 3160) 1.25 (0.98–1.59) .08 1.14 (0.89–1.48) .30 1.11 (0.86–1.45) .40
  NH black (N = 1166) 1.04 (0.67–1.61) .87 0.96 (0.62–1.50) .87 1.03 (0.65–1.63) .90
  MA (N = 1283) 1.17 (0.67–2.04) .58 1.11 (0.64–1.9) .71 1.06 (0.59–1.92) .84
  ≤65 y (N = 3216) 1.19 (0.77–1.85) .44 0.94 (0.60–1.44) .78 0.93 (0.59–1.45) .74
  >65 y (N = 2660) 1.17 (0.92–1.50) .20 1.16 (0.90–1.50) .26 1.15 (0.88–1.49) .30
  PIR < 100% (N = 932) 0.64 (0.39–1.05) .074 0.72 (0.44–1.18) .19 0.67 (0.41–1.11) .12
  PIR: 100–200% (N = 1451) 0.97 (0.65–1.45) .87 0.97 (0.65–1.45) .87 0.94 (0.61–1.45) .79
  PIR: >200% (N = 2712) 1.43 (1.03–1.99) .032 1.42 (1.01–1.98) .044 1.40 (0.99–1.97) .06
  <HS (N = 1858) 0.96 (0.63–1.47) .85 0.95 (0.62–1.46) .81 0.90 (0.58–1.40) .65
  HS (N = 2388) 1.06 (0.76–1.46) .75 1.05 (0.75–1.45) .79 1.06 (0.77–1.48) .71
  >HS (N = 1598) 1.31 (0.85–2.01) .23 1.32 (0.86–2.02) .21 1.32 (0.85–2.05) .21
All-cause dementia
  Overall (N = 5865) 1.09 (0.93–1.27) .30 1.03 (0.88–1.21) .71 1.01 (0.86–1.18) .89
  Men (N = 2932) 1.32 (1.05–1.65) .018§ 1.24 (0.98–1.56) .07§ 1.23 (0.97–1.56) .09§
  Women (N = 2933) 0.97 (0.78–1.19) .74 0.92 (0.75–1.14) .45 0.91 (0.73–1.12) .36
  NH white (N = 3157) 1.08 (0.90–1.29) .41 1.00 (0.83–1.20) .98 0.98 (0.82–1.18) .86
  NH black (N = 1164) 1.20 (0.88–1.64) .24 1.17 (0.86–1.60) .32 1.21 (0.88–1.65) .24
  MA (N = 1279) 0.93 (0.63–1.36) .70 0.87 (0.60–1.27) .47 0.83 (0.56–1.22) .34
  ≤65 y (N = 3213) 1.13 (0.84–1.52) .41 0.97 (0.72–1.31) .86 1.00 (0.74–1.35) .99
  >65 y (N = 2652) 1.03 (0.87–1.23) .72 1.02 (0.85–1.21) .86 1.00 (0.83–1.20) 1.00
  PIR < 100% (N = 925) 0.72 (0.50–1.04) .08 0.77 (0.53–1.12) .18 0.71 (0.50–1.01) .06
  PIR: 100–200% (N = 1449) 0.89 (0.66–1.20) .45 0.89 (0.67–1.21) .48 0.89 (0.66–1.21) .47
  PIR: >200% (N = 2712) 1.20 (0.96–1.51) .11 1.19 (0.94–1.50) .14 1.18 (0.93–1.49) .18
  <HS (N = 1849) 0.89 (0.65–1.22) .46 0.84 (0.61–1.16) .30 0.85 (0.61–1.18) .33
  HS (N = 2388) 1.01 (0.81–1.27) .90 1.00 (0.80–1.26) .99 1.01 (0.80–1.26) .95
  >HS (N = 1596) 1.18 (0.87–1.61) .28 1.18 (0.88–1.60) .28 1.18 (0.87–1.60) .30
NHANES III, phase 1
 Alzheimer’s disease
  Overall (N = 3646) 1.30 (1.00–1.69) .048 1.23 (0.94–1.62) .13 1.21 (0.92–1.60) .17
  Men (N= 1856) 2.03 (1.32–3.11) .001§ 1.95 (1.23–3.08) .004§ 1.99 (1.24–3.17) .004§
  Women (N = 1790) 1.05 (0.76–1.46) .76 0.98 (0.70–1.37) .89 0.96 (0.68–1.35) .81
  NH white (N = 2073) 1.30 (0.97–1.74) .08 1.21 (0.89–1.64) .22 1.19 (0.87–1.62) .28
  NH black (N = 767) 1.08 (0.67–1.75) .75 1.03 (0.64–1.65) .90 1.16 (0.71–1.89) .56
  MA (N = 710) 1.17 (0.58–2.34) .66 1.07 (0.53–2.16) .86 1.06 (0.50–2.27) .88
  ≤65 y (N = 1949) 1.23 (0.77–1.96) .39 0.96 (0.60–1.52) .85 0.97 (0.61–1.55) .90
  >65 y (N = 1697) 1.27 (0.94–1.73) .12 1.28 (0.93–1.76) .13 1.24 (0.89–1.73) .20
  PIR < 100% (N = 570) 0.84 (0.46–1.54) .58 0.80 (0.43–1.50) .49 0.69 (0.37–1.27) .23
  PIR: 100–200% (N = 906) 1.13 (0.68–1.89) .64 1.12 (0.67–1.89) .66 1.19 (0.68–2.08) .54
  PIR: >200% (N = 1729) 1.34 (0.93–1.95) .11 1.35 (0.91–1.98) .13 1.30 (0.88–1.93) .19
  <HS (N = 852) 0.76 (0.44–1.32) .34 0.71 (0.41–1.23) .22 0.66 (0.38–1.15) .14
  HS (N = 1924) 1.12 (0.80–1.59) .50 1.09 (0.77–1.54) .64 1.09 (0.77–1.55) .62
  >HS (N = 846) 1.75 (1.02–3.00) .044 1.75 (1.01–3.02) .046 1.84 (1.05–3.22) .032
 All-cause dementia
  Overall (N = 3646) 1.18 (0.98–1.42) .07 1.13 (0.93–1.36) .21 1.11 (0.92–1.34) .28
  Men (N = 1856) 1.51 (1.13–2.01) .005§ 1.44 (1.06–1.95) .020§ 1.44 (1.05–1.98) .022§
  Women (N = 1790) 1.04 (0.82–1.31) .77 0.98 (0.77–1.25) .88 0.97 (0.76–1.24) .82
  NH white (N = 2073) 1.16 (0.94–1.43) .16 1.10 (0.89–1.35) .40 1.09 (0.87–1.35) .45
  NH black (N = 767) 1.06 (0.74–1.52) .74 1.04 (0.73–1.49) .82 1.13 (0.78–1.63) .52
  MA (N = 710) 1.06 (0.67–1.69) .80 0.98 (0.62–1.54) .91 0.92 (0.58–1.47) .73
  ≤65 y (N = 1949) 1.16 (0.84–1.60) .37 0.96 (0.69–1.34) .83 0.98 (0.70–1.38) .92
  >65 y (N = 1697) 1.14 (0.91–1.41) .25 1.13 (0.91–1.40) .28 1.10 (0.88–1.38) .42
  PIR < 100% (N = 570) 0.72 (0.46–1.12) .15 0.71 (0.46–1.10) .13 0.61 (0.39–0.95) .030
  PIR: 100%−200% (N = 906) 1.08 (0.76–1.55) .66 1.08 (0.76–1.55) .66 1.11 (0.77–1.60) .57
  PIR: >200% (N = 1729) 1.24 (0.95–1.62) .11 1.22 (0.93–1.60) .15 1.20 (0.91–1.58) .19
  <HS (N = 852) 0.78 (0.50–1.22) .28 0.74 (0.48–1.16) .19 0.72 (0.46–1.12) .15
  HS (N = 1924) 1.05 (0.82–1.33) .71 1.02 (0.80–1.29) .89 1.02 (0.80–1.30) .90
  >HS (N = 846) 1.60 (1.09–2.35) .017§ 1.59 (1.08–2.34) .018 1.57 (1.06–2.31) .023

Abbreviations: BMI, body mass index; H. pylori (Hp), Helicobacter pylori; HR, hazard ratio; HS, high school; N, unweighted sample size; NH, non-Hispanic; NHANES, National Health and Nutrition Examination Surveys; PIR, poverty income ratio; MA, Mexican-American.

NOTE. Bold text indicates P<.05. Bold and italic text indicates P<.10.

*

Cox proportional hazards models with time of follow-up expressed in months since MEC examination. Model 1 was adjusted for age, sex, race, and wave. All models including sampling weights that are specific to NHANES III, phase 1 or combined for the pooled sample. Sample sizes shown are unweighted.

Model 2 is model 1 further adjusted for education and poverty income ratio.

Model 3 is model 2 further adjusted for smoking, weight status, hypertension, diabetes, and dyslipidemia.

§

P<.05 for interaction term Hp × sex in separate model with Hp and sex retained as main effects.

P<.05 for interaction term Hp × PIR in separate model with Hp and PIR group retained as main effects.

P<.05 for interaction term Hp × EDU in separate model with Hp and EDU group retained as main effects.